These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

948 related articles for article (PubMed ID: 18656012)

  • 1. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
    J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
    J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
    Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
    Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
    Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
    Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
    Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
    J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
    Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
    Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
    Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
    J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
    Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the art: radiolabeled microspheres treatment for liver malignancies.
    Deleporte A; Flamen P; Hendlisz A
    Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
    Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
    J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
    Bangash AK; Atassi B; Kaklamani V; Rhee TK; Yu M; Lewandowski RJ; Sato KT; Ryu RK; Gates VL; Newman S; Mandal R; Gradishar W; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 May; 18(5):621-8. PubMed ID: 17494843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
    Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP
    J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A first report of radioembolization for hepatic metastases from ocular melanoma.
    Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
    Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
    Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
    Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
    Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
    J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.